Clinical Trials Directory

Trials / Unknown

UnknownNCT05879237

Role of Vitamin D Supplementation as an Adjuvant Therapy inTreatment of Helicobacter Pylori in Children

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Minia University · Academic / Other
Sex
All
Age
4 Years – 18 Years
Healthy volunteers
Accepted

Summary

To study the efficacy of vitamin D in conjunction with Helicobacter pylori treatment in children in eradication of helicobacter pylori.

Detailed description

o study the efficacy of vitamin D in conjunction with Helicobacter pylori treatment in children in eradication of helicobacter pylori. our study include 2 patient groups: 1. st group included 100 child diagnosed Helicobacter pylori infection by upper gastrointestinal endoscopy and biopsies with pathology, will receive H.pylori eradication treatment and vitamin D as an adjuvant therapy . 2. nd group will also diagnosed Helicobacter pylori infection by upper gastrointestinal endoscopy and biopsies with pathology, will receive H.pylori eradication treatment only. Helicobacter pylori treatment : 1. amoxcillin on 50 mg/kg/day for 2 weeks 2. clarithromycin 20mg/kg/day for 2 weeks 3. proton pump inhibitor 1mg/kg/day for 1month Vitamin d dose..1000unit /day for 1 month

Conditions

Interventions

TypeNameDescription
DRUGVitamin D3Vitamin D3 ,1000 unit ,once daily, oral, for 1 month plus triple therapy
DRUGHelicobacter pylori triple therapyTriple therapy which is: amoxcillin on 50 mg/kg/day for 2 weeks, Clarithromycin 20mg/kg/day for 2 weeks and proton pump inhibitor 3.ppi 1mg/kg/day for 1month

Timeline

Start date
2023-06-01
Primary completion
2023-12-01
Completion
2023-12-10
First posted
2023-05-30
Last updated
2023-05-30

Source: ClinicalTrials.gov record NCT05879237. Inclusion in this directory is not an endorsement.